Financhill
Back

Akoya Biosciences Quote, Financials, Valuation and Earnings

Akoya Biosciences Price Quote

$3.19
+0.41 (+14.75%)
(Updated: October 7, 2024 at 1:50 PM ET)

Akoya Biosciences Key Stats

Sell
34
Akoya Biosciences (AKYA) is a Sell

Day range:
$2.50 - $2.81
52-week range:
$1.88 - $6.31
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.47
P/B ratio:
6.18%

Volume:
212K
Avg. volume:
136.6K
1-year change:
-27.98%
Market cap:
$137.6M
Revenue:
$96.6M
EPS:
$-1.23

How Much Does Akoya Biosciences Make?

Is Akoya Biosciences Growing As A Company?

  • What Is Akoya Biosciences's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.02%
  • What Is Akoya Biosciences's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Akoya Biosciences Stock Price Performance

What Is Akoya Biosciences 52-Week High & Low?

Akoya Biosciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Akoya Biosciences?

  • How Much Debt Does Akoya Biosciences Have?
    Total long term debt quarterly is $75.7M
  • How Much Cash Does Akoya Biosciences Have?
    Cash and short term investments quarterly total is $45.2M
  • What Is Akoya Biosciences’s Book Value Per Share?
    Book value per share is 0.45

Is Akoya Biosciences Cash Flow Positive?

  • What Is AKYA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$51.2M
  • What Is Akoya Biosciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $8.4M
  • What Is Akoya Biosciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$41.2M

Akoya Biosciences Return On Invested Capital

  • Is Management Doing A Good Job?
    AKYA return on invested capital is -50.59%
  • What Is Akoya Biosciences Return On Assets?
    ROA measures how assets are converting to revenues and is -35.71%
  • What Is AKYA Return On Equity?
    ROE is a measure of profitability and is -124.38%

Akoya Biosciences Earnings Date & Stock Price

Akoya Biosciences Competitors

Akoya Biosciences Dividend Yield

Akoya Biosciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 1.59%
Revenue: -1.52% -1.65%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 4
Sell Recommendations: 0
Price Target: 5.00
Upside from Last Price: 79.86%

Major Shareholders

  • How many AKYA shares are owned by institutional investors?
    24.4M AKYA shares are owned by institutional investors
  • How many AKYA shares are owned by insiders?
    3.3M AKYA shares are owned by insiders